VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Aug 01, 2020 To Aug 12, 2020:


Bacillus anthracis (Anthrax)

  1. Sarker MSA, El Zowalaty ME, Shahid MAH, Sarker MA, Rahman MB, Järhult JD, Nazir KHMNH. Maximization of Livestock Anthrax Vaccination Coverage in Bangladesh: An Alternative Approach Vaccines 8(3) 2020 [PMID: 32759647]

Brucella (Brucellosis)

  1. Sheehan LM, Budnick JA, Fyffe-Blair J, King KA, Settlage RE, Caswell CC. The endoribonuclease RNaseE coordinates expression of mRNAs and small regulatory RNAs and is critical for the virulence of <i>Brucella abortus</i> Journal of bacteriology 2020 [PMID: 32747427]
  2. Yang J, Wang G, Li H, Zheng W, Guo B, Wang Z. Knockdown of Mg<sup>2+/</sup>Mn<sup>2+</sup> dependent protein phosphatase 1A promotes apoptosis in BV2 cells infected with <i>Brucella suis</i> strain 2 vaccine Experimental and therapeutic medicine 20(2):926-932 2020 [PMID: 32742335]
  3. Vyas S, Dhoble S, Ghodake V, Patravale V. Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology International journal of pharmaceutics: X 2:100053 2020 [PMID: 32776000]
  4. Wei C, Yang WH, Hou XX, Yang HY, Sun LN, Zhou DS, Li ZJ. [Immunization efficacy and safety of <i>Brucella</i> 104M against aerosol challenge in BALB/c mice] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 41(7):1103-1109 2020 [PMID: 32741179]

Clostridium botulinum toxin (Botulism)

  1. Behrensdorf-Nicol HA, Bonifas U, Klimek J, Hanschmann KM, Dorner BG, Hohenadl C, Töllner L, Kegel B, Krämer B. Transferability study of the BINACLE (binding and cleavage) assay for in vitro determination of botulinum neurotoxin activity Biologicals : journal of the International Association of Biological Standardization 2020 [PMID: 32739117]

Clostridium perfringens

  1. Santos FDS, Ferreira MRA, Maubrigades LR, Gonçalves VS, de Lara APS, Moreira C, Salvarani FM, Conceição FR, Leivas Leite FP. Bacillus toyonensis BCT-7112<sup>T</sup> transient supplementation improves vaccine efficacy in ewes vaccinated against Clostridium perfringens epsilon toxin Journal of applied microbiology 2020 [PMID: 32767796]

Coronavirus

  1. Israelow B, Song E, Mao T, Lu P, Meir A, Liu F, Alfajaro MM, Wei J, Dong H, Homer RJ, Ring A, Wilen CB, Iwasaki A. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling The Journal of experimental medicine 217(12) 2020 [PMID: 32750141]
  2. Jo S, Kim S, Kim DY, Kim MS, Shin DH. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro Journal of enzyme inhibition and medicinal chemistry 35(1):1539-1544 2020 [PMID: 32746637]
  3. Ullrich S, Nitsche C. The SARS-CoV-2 main protease as drug target Bioorganic & medicinal chemistry letters 30(17):127377 2020 [PMID: 32738988]
  4. Olson DJ, Ghosh A, Zhang AY. Ophthalmic manifestations of coronavirus disease 2019 and ocular side effects of investigational pharmacologic agents Current opinion in ophthalmology 31(5):403-415 2020 [PMID: 32740062]
  5. Li QY, Cheng Q, Zhao ZL, Dai NN, Zeng L, Zhu L, Guo W, Li C, Wang JH, Li S, Ge QG, Shen N. [Severe acute respiratory syndrome coronavirus 2 infection in renal transplant recipients: A case report] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 52(4):780-784 2020 [PMID: 32773818]
  6. Srivastava Y, Sassaroli E, Swain J, Widom A, Narain M, de Montmollin G. Non-chemical signatures of biological materials: Radio signals from Covid19? Electromagnetic biology and medicine :1-7 2020 [PMID: 32772742]
  7. Vanderslott S, Marks T. Travel restrictions as a disease control measure: Lessons from yellow fever Global public health :1-14 2020 [PMID: 32772788]
  8. Devi A, Chaitanya NSN. <i>In silico</i> designing of multi-epitope vaccine construct against human coronavirus infections Journal of biomolecular structure & dynamics :1-15 2020 [PMID: 32772892]
  9. Sallard E, Halloy J, Casane D, van Helden J, Decroly É. [Tracing the origins of SARS-COV-2 in coronavirus phylogenies] Medecine sciences : M/S 2020 [PMID: 32773024]
  10. Stoian AP, Toth PP, Kempler P, Rizzo M. Gender differences in the battle against COVID-19: impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes International journal of clinical practice :e13666 2020 [PMID: 32770758]
  11. den Hartog G, Schepp RM, Kuijer M, GeurtsvanKessel C, van Beek J, Rots N, Koopmans MPG, van der Klis FRM, van Binnendijk RS. SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence The Journal of infectious diseases 2020 [PMID: 32766833]
  12. Choudhery MS, Harris DT. Stem Cell Therapy for Covid-19: Possibilities and Challenges Cell biology international 2020 [PMID: 32767687]
  13. Vashishtha VM. Are BCG-induced non-specific effects adequate to provide protection against COVID-19? Human vaccines & immunotherapeutics :1-4 2020 [PMID: 32762516]
  14. Alazmi M, Motwalli O. <i>In silico</i> virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins Journal of biomolecular structure & dynamics :1-11 2020 [PMID: 32762537]
  15. Kaniyala Melanthota S, Banik S, Chakraborty I, Pallen S, Gopal D, Chakrabarti S, Mazumder N. Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs Microscopy research and technique 2020 [PMID: 32770582]
  16. Faheem M, Singh VK. Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP Mini reviews in medicinal chemistry 2020 [PMID: 32767940]
  17. Sarkar K, Sil PC, Nabavi SF, Neagoe IB, Cismaru CA, Nabavi SM, Habtemariam S. Possible Targets and Therapies of SARS-CoV-2 Infection Mini reviews in medicinal chemistry 2020 [PMID: 32767936]
  18. Yuen E, Gudis DA, Rowan NR, Nguyen SA, Schlosser RJ. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists American journal of rhinology & allergy :1945892420947929 2020 [PMID: 32762250]
  19. Barello S, Nania T, Dellafiore F, Graffigna G, Caruso R. 'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic European journal of epidemiology 2020 [PMID: 32761440]
  20. Ma X, Liang M, Ding M, Liu W, Ma H, Zhou X, Ren H. Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS) Medical science monitor : international medical journal of experimental and clinical research 26:e925364 2020 [PMID: 32759887]
  21. Liang H, Zheng L, Xia H, Tang J. SARS-CoV-2 infection in China-Before the pandemic PLoS neglected tropical diseases 14(8):e0008472 2020 [PMID: 32760070]
  22. Wang J, Peng Y, Xu H, Cui Z, Williams RO 3rd. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation AAPS PharmSciTech 21(6):225 2020 [PMID: 32761294]
  23. Levy E, Delvin E, Marcil V, Spahis S. MAY PHYTOTHERAPY WITH POLYPHENOLS SERVE AS A POWERFUL APPROACH FOR THE PREVENTION AND THERAPY TOOL OF NOVEL CORONAVIRUS DISEASE 2019 (COVID-19)? American journal of physiology. Endocrinology and metabolism 2020 [PMID: 32755302]
  24. Gupta I, Rizeq B, Elkord E, Vranic S, Al Moustafa AE. SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities Cancers 12(8) 2020 [PMID: 32764454]
  25. Lam S, Lombardi A, Ouanounou A. COVID-19: A review of the proposed pharmacological treatments European journal of pharmacology :173451 2020 [PMID: 32768505]
  26. Ezzikouri S, Nourlil J, Benjelloun S, Kohara M, Tsukiyama-Kohara K. Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development Human vaccines & immunotherapeutics :1-9 2020 [PMID: 32755425]
  27. Talukder A. Effect of Age on Death Due to Coronavirus Disease 2019 (COVID-19): Application of Poisson Regression Model International journal of clinical practice :e13649 2020 [PMID: 32757345]
  28. Joshi T, Joshi T, Pundir H, Sharma P, Mathpal S, Chandra S. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease Journal of biomolecular structure & dynamics :1-19 2020 [PMID: 32752947]
  29. Siddiqui AJ, Jahan S, Ashraf SA, Alreshidi M, Ashraf MS, Patel M, Snoussi M, Singh R, Adnan M. Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2 Journal of biomolecular structure & dynamics :1-14 2020 [PMID: 32752944]
  30. Moura RR, Agrelli A, Santos-Silva CA, Silva N, Assunção BR, Brandão L, Benko-Iseppon AM, Crovella S. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population Journal of clinical pathology 2020 [PMID: 32759312]
  31. Ferreira AO, Polonini HC, Dijkers ECF. Postulated Adjuvant Therapeutic Strategies for COVID-19 Journal of personalized medicine 10(3) 2020 [PMID: 32764275]
  32. Iseni F, Tournier JN. [A race against the clock: creation of SARS-Cov-2 in the laboratory, a month after its emergence!] Medecine sciences : M/S 2020 [PMID: 32755538]
  33. Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schäfer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, Martinez DR, Bock KW, Minai M, Nagata BM, Hutchinson GB, Wu K, Henry C, Bahi K, Garcia-Dominguez D, Ma L, Renzi I, Kong WP, Schmidt SD, Wang L, Zhang Y, Phung E, Chang LA, Loomis RJ, Altaras NE, Narayanan E, Metkar M, Presnyak V, Liu C, Louder MK, Shi W, Leung K, Yang ES, West A, Gully KL, Stevens LJ, Wang N, Wrapp D, Doria-Rose NA, Stewart-Jones G, Bennett H, Alvarado GS, Nason MC, Ruckwardt TJ, McLellan JS, Denison MR, Chappell JD, Moore IN, Morabito KM, Mascola JR, Baric RS, Carfi A, Graham BS. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Nature 2020 [PMID: 32756549]
  34. Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics Biological procedures online 22:19 2020 [PMID: 32774178]
  35. Khan S, Tombuloglu H, Hassanein SE, Rehman S, Bozkurt A, Cevik E, Abdel-Ghany S, Nabi G, Ali A, Sabit H. Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective European journal of pharmacology :173447 2020 [PMID: 32763302]
  36. Habas K, Nganwuchu C, Shahzad F, Gopalan R, Haque M, Rahman S, Majumder AA, Nasim T. Resolution of coronavirus disease 2019 (COVID-19) Expert review of anti-infective therapy :1-11 2020 [PMID: 32749914]
  37. Yang X, Liu Y, Liu Y, Yang Q, Wu X, Huang X, Liu H, Cai W, Ma G. Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges Expert review of clinical pharmacology 2020 [PMID: 32746653]
  38. Almaghaslah D, Kandasamy G, Almanasef M, Vasudevan R, Chandramohan S. Review on the coronavirus disease (COVID-19) pandemic: its outbreak and current status International journal of clinical practice :e13637 2020 [PMID: 32750190]
  39. Patra R, Chandra Das N, Mukherjee S. Targeting human TLRs to combat COVID-19: A solution? Journal of medical virology 2020 [PMID: 32749702]
  40. McCallum M, Walls AC, Bowen JE, Corti D, Veesler D. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation Nature structural & molecular biology 2020 [PMID: 32753755]
  41. Shah N, Davariya V, Gupta SK, Gajjar P, Parmar J, D'Cruz L. Review: An insight into coronaviruses: Challenges, security and scope Reviews in medical virology :e2138 2020 [PMID: 32754974]
  42. Kasilingam D, Prabhakaran SPS, Dinesh Kumar R, Rajagopal V, Santhosh Kumar T, Soundararaj A. Exploring the Growth of COVID-19 Cases using Exponential Modelling Across 42 Countries and Predicting Signs of Early Containment using Machine Learning Transboundary and emerging diseases 2020 [PMID: 32749759]
  43. Jamshaid H, Zahid F, Din IU, Zeb A, Choi HG, Khan GM, Din FU. Diagnostic and Treatment Strategies for COVID-19 AAPS PharmSciTech 21(6):222 2020 [PMID: 32748244]
  44. Jarvis MA, Hansen FA, Rosenke K, Haddock E, Rollinson C, Rule S, Sewell G, Hughes A, Feldmann H. Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system Antiviral therapy 2020 [PMID: 32744511]
  45. Tan EJ, Meyer D, Neill E, Phillipou A, Toh WL, Van Rheenen TE, Rossell SL. Considerations for assessing the impact of the COVID-19 pandemic on mental health in Australia The Australian and New Zealand journal of psychiatry :4867420947815 2020 [PMID: 32746614]
  46. Wang K, Long QX, Deng HJ, Hu J, Gao QZ, Zhang GJ, He CL, Huang LY, Hu JL, Chen J, Tang N, Huang AL. Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 [PMID: 32745196]
  47. Rudrapal M, Khairnar SJ, Borse LB, Jadhav AG. Coronavirus Disease-2019 (COVID-19): An Updated Review Drug research 2020 [PMID: 32746481]
  48. Sharun K, Tiwari R, Iqbal Yatoo M, Patel SK, Natesan S, Dhama J, Malik YS, Harapan H, Singh RK, Dhama K. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects Expert opinion on biological therapy :1-14 2020 [PMID: 32744917]
  49. Urashima M, Otani K, Hasegawa Y, Akutsu T. BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study International journal of environmental research and public health 17(15) 2020 [PMID: 32756371]
  50. Zhand S, Saghaeian Jazi M, Mohammadi S, Tarighati Rasekhi R, Rostamian G, Kalani MR, Rostamian A, George J, Douglas MW. COVID-19: The Immune Responses and Clinical Therapy Candidates International journal of molecular sciences 21(15) 2020 [PMID: 32756480]
  51. Fakhar Z, Faramarzi B, Pacifico S, Faramarzi S. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic Journal of biomolecular structure & dynamics :1-13 2020 [PMID: 32741312]
  52. Chikhale RV, Gupta VK, Eldesoky GE, Wabaidur SM, Patil SA, Islam MA. Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies Journal of biomolecular structure & dynamics :1-16 2020 [PMID: 32741259]
  53. Hedde PN, Abram TJ, Jain A, Nakajima R, Ramiro de Assis R, Pearce T, Jasinskas A, Toosky MN, Khan S, Felgner PL, Gratton E, Zhao W. A modular microarray imaging system for highly specific COVID-19 antibody testing Lab on a chip 2020 [PMID: 32743622]
  54. Dhama K, Patel SK, Sharun K, Pathak M, Tiwari R, Yatoo MI, Malik YS, Sah R, Rabaan AA, Panwar PK, Singh KP, Michalak I, Chaicumpa W, Martinez-Pulgarin DF, Bonilla-Aldana DK, Rodriguez-Morales AJ. SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus Travel medicine and infectious disease :101830 2020 [PMID: 32755673]
  55. Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression Advances in biological regulation 77:100741 2020 [PMID: 32773102]
  56. Hussain A, Hasan A, Nejadi Babadaei MM, Bloukh SH, Chowdhury MEH, Sharifi M, Haghighat S, Falahati M. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 130:110559 2020 [PMID: 32768882]
  57. . Accelerating regulation in response to COVID-19 Bulletin of the World Health Organization 98(8):514-515 2020 [PMID: 32773895]
  58. Gyles C. Coronavirus vaccines The Canadian veterinary journal = La revue veterinaire canadienne 61(8):813-814 2020 [PMID: 32741988]
  59. Sharifi H, Jahani Y, Mirzazadeh A, Ahmadi Gohari M, Nakhaeizadeh M, Shokoohi M, Eybpoosh S, Tohidinik HR, Mostafavi E, Khalili D, Hashemi Nazari SS, Karamouzian M, Haghdoost AA. Estimating COVID-19-Related Infections, Deaths, and Hospitalizations in Iran Under Different Physical Distancing and Isolation Scenarios International journal of health policy and management 2020 [PMID: 32772007]
  60. Sharma AK, Ahmed A, Baig VN, Dhakar P, Dalela G, Kacker S, Panwar VR, Panwar RB, Gupta R. Characteristics and Outcomes of Hospitalized Young Adults with Mild Covid -19 The Journal of the Association of Physicians of India 68(8):62-65 2020 [PMID: 32738843]
  61. Cyranoski D. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes Nature 584(7819):17-18 2020 [PMID: 32737453]
  62. Cheng GS, Hill JA. To Toci or Not to Toci for COVID-19: Is That Still the Question? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 [PMID: 32735642]
  63. Krishna G, Pillai VS, Veettil MV. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection European journal of pharmacology 885:173450 2020 [PMID: 32739174]
  64. Richmond H, Rees N, McHale S, Rak A, Anderson J. Seasonal influenza vaccination during a pandemic Human vaccines & immunotherapeutics :1-3 2020 [PMID: 32735161]
  65. Kaur N, Singh R, Dar Z, Bijarnia RK, Dhingra N, Kaur T. Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2 Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases :104490 2020 [PMID: 32745811]
  66. Al-Shar'i NA. Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations Journal of biomolecular structure & dynamics :1-16 2020 [PMID: 32734828]
  67. Husayn SS, Brown JD, Presley CL, Boghean K, Waller JD. Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic Journal of pharmacy practice :897190020942658 2020 [PMID: 32734810]
  68. Sposato B, Scalese M. Why do children seem to be more protected against COVID-19? A hypothesis Medical hypotheses 143:110151 2020 [PMID: 32763661]
  69. Langdon-Embry M, Papadouka V, Cheng I, Almashhadani M, Ternier A, Zucker JR. Notes from the Field: Rebound in Routine Childhood Vaccine Administration Following Decline During the COVID-19 Pandemic - New York City, March 1-June 27, 2020 MMWR. Morbidity and mortality weekly report 69(30):999-991001 2020 [PMID: 32734936]
  70. Chakraborty R, Parvez S. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials Biochemical pharmacology :114184 2020 [PMID: 32739342]
  71. Kamiński M, Muth A, Bogdański P. Smoking, Vaping, and Tobacco Industry During COVID-19 Pandemic: Twitter Data Analysis Cyberpsychology, behavior and social networking 2020 [PMID: 32757951]
  72. Conzelmann C, Gilg A, Groß R, Schütz D, Preising N, Ständker L, Jahrsdörfer B, Schrezenmeier H, Sparrer KMJ, Stamminger T, Stenger S, Münch J, Müller JA. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection Antiviral research 181:104882 2020 [PMID: 32738255]
  73. Lee SH, Jee SW, Hwang DY, Kang JK. Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2 Laboratory animal research 36:23 2020 [PMID: 32733785]
  74. Biterge Süt B. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13 Life sciences 258:118170 2020 [PMID: 32735883]
  75. Lim RK, Wambier CG, Goren A. Are night shift workers at an increased risk for COVID-19? Medical hypotheses 144:110147 2020 [PMID: 32758906]
  76. Shirvani E, Samal SK. Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2 Pathogens (Basel, Switzerland) 9(8) 2020 [PMID: 32751194]
  77. Russo M, Moccia S, Spagnuolo C, Tedesco I, Russo GL. Roles of flavonoids against coronavirus infection Chemico-biological interactions 328:109211 2020 [PMID: 32735799]
  78. Zheng L, Zhang L, Huang J, Nandakumar KS, Liu S, Cheng K. Potential treatment methods targeting 2019-nCoV infection European journal of medicinal chemistry 205:112687 2020 [PMID: 32771797]
  79. Otto DP, de Villiers MM. Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections Molecules (Basel, Switzerland) 25(15) 2020 [PMID: 32731428]
  80. Rahman N, Ali F, Basharat Z, Shehroz M, Khan MK, Jeandet P, Nepovimova E, Kuca K, Khan H. Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach Vaccines 8(3) 2020 [PMID: 32731461]
  81. Hamed MGM, Hagag RS. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients Medical hypotheses 144:110140 2020 [PMID: 32768893]
  82. McClain MT, Constantine FJ, Henao R, Liu Y, Tsalik EL, Burke TW, Steinbrink JM, Petzold E, Nicholson BP, Rolfe R, Kraft BD, Kelly MS, Sempowski GD, Denny TN, Ginsburg GS, Woods CW. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery support novel diagnostic approaches medRxiv : the preprint server for health sciences 2020 [PMID: 32743603]
  83. Kilic T, Weissleder R, Lee H. Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges iScience 23(8):101406 2020 [PMID: 32771976]
  84. Khan S, Siddique R, Bai Q, Shabana, Liu Y, Xue M, Nabi G, Liu J. Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options Journal of infection and public health 2020 [PMID: 32741731]
  85. Zhao P, Praissman JL, Grant OC, Cai Y, Xiao T, Rosenbalm KE, Aoki K, Kellman BP, Bridger R, Barouch DH, Brindley MA, Lewis NE, Tiemeyer M, Chen B, Woods RJ, Wells L. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor bioRxiv : the preprint server for biology 2020 [PMID: 32743578]
  86. Zolfaghari Emameh R, Nosrati H, Eftekhari M, Falak R, Khoshmirsafa M. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19 Biological procedures online 22:16 2020 [PMID: 32754004]
  87. Barati F, Pouresmaieli M, Ekrami E, Asghari S, Ziarani FR, Mamoudifard M. Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review Biological procedures online 22:15 2020 [PMID: 32754003]
  88. Ahmad J, Ikram S, Ahmad F, Rehman IU, Mushtaq M. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study Heliyon 6(7):e04502 2020 [PMID: 32754651]
  89. Ye C, Chiem K, Park JG, Oladunni F, Platt RN, Anderson T, Almazan F, de la Torre JC, Martinez-Sobrido L. Rescue of SARS-CoV-2 from a single bacterial artificial chromosome bioRxiv : the preprint server for biology 2020 [PMID: 32743573]
  90. Badgujar KC, Badgujar VC, Badgujar SB. Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges Diabetes & metabolic syndrome 14(5):1361-1376 2020 [PMID: 32755836]
  91. Libotte GB, Lobato FS, Platt GM, Silva Neto AJ. Determination of an optimal control strategy for vaccine administration in COVID-19 pandemic treatment Computer methods and programs in biomedicine 196:105664 2020 [PMID: 32736332]
  92. Samrah SM, W Al-Mistarehi AH, Ibnian AM, Raffee LA, Momany SM, Al-Ali M, Hayajneh WA, Yusef DH, Awad SM, Khassawneh BY. COVID-19 outbreak in Jordan: Epidemiological features, clinical characteristics, and laboratory findings Annals of medicine and surgery (2012) 57:103-108 2020 [PMID: 32742648]
  93. Xing Y, Li X, Gao X, Dong Q. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein Frontiers in genetics 11:783 2020 [PMID: 32765596]
  94. Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia Frontiers in public health 8:381 2020 [PMID: 32760691]
  95. Naz A, Shahid F, Butt TT, Awan FM, Ali A, Malik A. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach Frontiers in immunology 11:1663 2020 [PMID: 32754160]
  96. Ahsan W, Alhazmi HA, Patel KS, Mangla B, Al Bratty M, Javed S, Najmi A, Sultan MH, Makeen HA, Khalid A, Mohan S, Taha MME, Sultana S. Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19 Frontiers in public health 8:384 2020 [PMID: 32754570]
  97. Kulyar MF, Li R, Mehmood K, Waqas M, Li K, Li J. Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic Phytomedicine : international journal of phytotherapy and phytopharmacology :153277 2020 [PMID: 32773257]
  98. Lackland DT, Sims-Robinson C, Jones Buie JN, Voeks JH. Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations Ethnicity & disease 30(3):429-432 2020 [PMID: 32742146]
  99. Laviada-Molina HA, Leal-Berumen I, Rodriguez-Ayala E, Bastarrachea RA. Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine? Frontiers in endocrinology 11:514 2020 [PMID: 32733388]
  100. Bangash FS, Saeed G, Shahab P, Waheed A. COVID-19: An Update Regarding the Quest for Finding an Effective Cure Cureus 12(7):e9010 2020 [PMID: 32775090]
  101. Álvez F. SARS-CoV2 coronavirus: so far polite with children. Debatable immunological and non-immunological evidence Allergologia et immunopathologia 2020 [PMID: 32771236]
  102. Dos Santos WG. Natural history of COVID-19 and current knowledge on treatment therapeutic options Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 129:110493 2020 [PMID: 32768971]
  103. Case JB, Rothlauf PW, Chen RE, Liu Z, Zhao H, Kim AS, Bloyet LM, Zeng Q, Tahan S, Droit L, Ilagan MXG, Tartell MA, Amarasinghe G, Henderson JP, Miersch S, Ustav M, Sidhu S, Virgin HW, Wang D, Ding S, Corti D, Theel ES, Fremont DH, Diamond MS, Whelan SPJ. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 Cell host & microbe 2020 [PMID: 32735849]
  104. Torequl Islam M, Nasiruddin M, Khan IN, Mishra SK, Kudrat-E-Zahan M, Alam Riaz T, Ali ES, Rahman MS, Mubarak MS, Martorell M, Cho WC, Calina D, Docea AO, Sharifi-Rad J. A Perspective on Emerging Therapeutic Interventions for COVID-19 Frontiers in public health 8:281 2020 [PMID: 32733837]
  105. Khajanchi S, Sarkar K. Forecasting the daily and cumulative number of cases for the COVID-19 pandemic in India Chaos (Woodbury, N.Y.) 30(7):071101 2020 [PMID: 32752627]
  106. Johnson BS, Laloraya M. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization Cytokine & growth factor reviews 2020 [PMID: 32747157]
  107. Vella F, Senia P, Ceccarelli M, Vitale E, Maltezou H, Taibi R, Lleshi A, Venanzi Rullo E, Pellicanò GF, Rapisarda V, Nunnari G, Ledda C. Transmission mode associated with coronavirus disease 2019: a review European review for medical and pharmacological sciences 24(14):7889-7904 2020 [PMID: 32744718]
  108. Abbasi Pashaki P, Habibi Roudkenar M, Rahim F, Ebrahimi A. From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality European review for medical and pharmacological sciences 24(14):7816-7825 2020 [PMID: 32744709]
  109. Ng QX, De Deyn MLZQ, Loke W, Yeo WS. Yemen's Cholera Epidemic Is a One Health Issue Journal of preventive medicine and public health = Yebang Uihakhoe chi 53(4):289-292 2020 [PMID: 32752599]
  110. Yaqinuddin A. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities Medical hypotheses 144:110049 2020 [PMID: 32758887]
  111. Khan I, Ahmed Z, Sarwar A, Jamil A, Anwer F. The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts Cureus 12(6):e8871 2020 [PMID: 32754408]
  112. Neupane K, Ahmed Z, Pervez H, Ashraf R, Majeed A. Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts Cureus 12(6):e8845 2020 [PMID: 32754388]
  113. Cashman DP. Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease Medical hypotheses 144:110027 2020 [PMID: 32758873]
  114. Hyoju SK, Zaborina O, van Goor H. SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol) Medical hypotheses 144:110039 2020 [PMID: 32758881]
  115. Srivastava S, Verma S, Kamthania M, Kaur R, Badyal RK, Saxena AK, Shin HJ, Kolbe M, Pandey KC. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation JMIR bioinformatics and biotechnology 1(1):e19371 2020 [PMID: 32776022]
  116. Van Norman GA. "Warp Speed" Operations in the COVID-19 Pandemic: Moving Too Quickly? JACC. Basic to translational science 5(7):730-734 2020 [PMID: 32760859]
  117. Shey M, Okeibunor JC, Yahaya AA, Herring BL, Tomori O, Coulibaly SO, Gumede-Moeletsi HN, Mwenda JM, Yoti Z, Wiysonge CS, Talisuna AO. Genome sequencing and the diagnosis of novel coronavirus (SARS-COV-2) in Africa: how far are we? The Pan African medical journal 36:80 2020 [PMID: 32774639]
  118. Sahu KK, Kumar R. Preventive and treatment strategies of COVID-19: From community to clinical trials Journal of family medicine and primary care 9(5):2149-2157 2020 [PMID: 32754463]
  119. Levy N, Savulescu J. Epistemic responsibility in the face of a pandemic Journal of law and the biosciences 7(1):lsaa033 2020 [PMID: 32733691]
  120. Lun Y, Liu B, Dong W, Sun J, Pan L. [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV] Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 49(3):315-323 2020 [PMID: 32762171]
  121. Stawicki SP, Jeanmonod R, Miller AC, Paladino L, Gaieski DF, Yaffee AQ, De Wulf A, Grover J, Papadimos TJ, Bloem C, Galwankar SC, Chauhan V, Firstenberg MS, Di Somma S, Jeanmonod D, Garg SM, Tucci V, Anderson HL, Fatimah L, Worlton TJ, Dubhashi SP, Glaze KS, Sinha S, Opara IN, Yellapu V, Kelkar D, El-Menyar A, Krishnan V, Venkataramanaiah S, Leyfman Y, Saoud Al Thani HA, Wb Nanayakkara P, Nanda S, Cioè-Peña E, Sardesai I, Chandra S, Munasinghe A, Dutta V, Dal Ponte ST, Izurieta R, Asensio JA, Garg M. The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper Journal of global infectious diseases 12(2):47-93 2020 [PMID: 32773996]
  122. Hakmi M, Bouricha EM, Kandoussi I, Harti JE, Ibrahimi A. Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis Bioinformation 16(4):301-306 2020 [PMID: 32773989]
  123. Pergolizzi JV Jr, Magnusson P, LeQuang JA, Breve F, Paladini A, Rekatsina M, Yeam CT, Imani F, Saltelli G, Taylor R Jr, Wollmuth C, Varrassi G. The Current Clinically Relevant Findings on COVID-19 Pandemic Anesthesiology and pain medicine 10(2):e103819 2020 [PMID: 32754437]
  124. Moazzen N, Imani B, Aelami MH, Motevali Haghi NS, Kianifar HR, Khoushkhui M, Ahanchian H. How to Boost our Immune System Against Coronavirus Infection? The archives of bone and joint surgery 8(Suppl 1):220-225 2020 [PMID: 32733978]
  125. Haeryfar SMM. MAIT Cells in COVID-19: Heroes, Villains, or Both? Critical reviews in immunology 40(2):173-184 2020 [PMID: 32749095]
  126. Abdullah SF, Sharquie IK. SARS-CoV-2: A Piece of Bad News Medeniyet medical journal 35(2):151-160 2020 [PMID: 32733765]

Coxiella burnetii (Q fever)

  1. Reeves PM, Raju Paul S, Baeten L, Korek SE, Yi Y, Hess J, Sobell D, Scholzen A, Garritsen A, De Groot AS, Moise L, Brauns T, Bowen R, Sluder AE, Poznansky MC. Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling Scientific reports 10(1):13311 2020 [PMID: 32770104]
  2. Husayn SS, Brown JD, Presley CL, Boghean K, Waller JD. Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic Journal of pharmacy practice :897190020942658 2020 [PMID: 32734810]

Ebola virus

  1. Kortepeter MG, Dierberg K, Shenoy ES, Cieslak TJ. Marburg Virus Disease: a Summary for Clinicians International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020 [PMID: 32758690]

Escherichia coli

  1. Lewnard JA, Rogawski McQuade ET, Platts-Mills JA, Kotloff KL, Laxminarayan R. Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: Evidence from the Global Enteric Multicenter Study PLoS neglected tropical diseases 14(8):e0008520 2020 [PMID: 32776938]
  2. Ali A, Kolenda R, Khan MM, Weinreich J, Li G, Wieler LH, Tedin K, Roggenbuck D, Schierack P. Identification of Avian Pathogenic <i>Escherichia coli</i>'s novel genes responsible for adhesion to chicken and human cell lines Applied and environmental microbiology 2020 [PMID: 32769194]
  3. O'Dowd K, Emam M, El Khili MR, Emad A, Ibeagha-Awemu EM, Gagnon CA, Barjesteh N. Distinct miRNA Profile of Cellular and Extracellular Vesicles Released from Chicken Tracheal Cells Following Avian Influenza Virus Infection Vaccines 8(3) 2020 [PMID: 32764349]
  4. Liu L, Tang H, Feng LL, Cheng TY. Hemalin from Haemaphysalis flava ticks: cloning, expression and antithrombogenicity Medical and veterinary entomology 2020 [PMID: 32748973]
  5. Siebert C, Mercier C, Martin DK, Renesto P, Schaack B. Physicochemical Evidence that <i>Francisella</i> FupA and FupB Proteins Are Porins International journal of molecular sciences 21(15) 2020 [PMID: 32752076]
  6. Kent-Dennis C, Aschenbach JR, Griebel PJ, Penner GB. Effects of lipopolysaccharide exposure in primary bovine ruminal epithelial cells Journal of dairy science 2020 [PMID: 32747102]
  7. Liu R, Guo H, Du P, Dong H, Guo M, Sun S. [Construction, expression and identification of chimeric foot-and-mouth disease virus-like particles] Sheng wu gong cheng xue bao = Chinese journal of biotechnology 36(7):1305-1313 2020 [PMID: 32748588]
  8. Wang J, Ishfaq M, Guo Y, Chen C, Li J. Assessment of Probiotic Properties of <i>Lactobacillus salivarius</i> Isolated From Chickens as Feed Additives Frontiers in veterinary science 7:415 2020 [PMID: 32766298]

Francisella tularensis (Tularemia)

  1. Roberts LM, Anderson R, Carmody A, Bosio CM. Validation and Application of a Bench Top Cell Sorter in a BSL-3 Containment Setting bioRxiv : the preprint server for biology 2020 [PMID: 32766573]
  2. Siebert C, Mercier C, Martin DK, Renesto P, Schaack B. Physicochemical Evidence that <i>Francisella</i> FupA and FupB Proteins Are Porins International journal of molecular sciences 21(15) 2020 [PMID: 32752076]

Hantavirus

  1. Warner BM, Jangra RK, Griffin BD, Stein DR, Kobasa D, Chandran K, Kobinger GP, Safronetz D. Oral Vaccination With Recombinant Vesicular Stomatitis Virus Expressing Sin Nombre Virus Glycoprotein Prevents Sin Nombre Virus Transmission in Deer Mice Frontiers in cellular and infection microbiology 10:333 2020 [PMID: 32733817]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Bauer AM, Bar KJ. Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure Current opinion in HIV and AIDS 15(5):275-281 2020 [PMID: 32769631]
  2. Danesh A, Ren Y, Brad Jones R. Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV Current opinion in HIV and AIDS 15(5):316-323 2020 [PMID: 32732552]
  3. Nyawanda BO, Otieno NA, Otieno MO, Emukule GO, Bigogo G, Onyango CO, Lidechi S, Nyaundi J, Langley GE, Widdowson MA, Chaves SS. The impact of maternal HIV infection on the burden of respiratory syncytial virus among pregnant women and their infants, western Kenya The Journal of infectious diseases 2020 [PMID: 32777041]
  4. Capitaine L, Genuer R, Thiébaut R. Random forests for high-dimensional longitudinal data Statistical methods in medical research :962280220946080 2020 [PMID: 32772626]
  5. Thomas SJ, Kilgore JT, Becken BA, Cunningham CK, Thompson AB. Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles Journal of the Pediatric Infectious Diseases Society 2020 [PMID: 32766769]
  6. Baruti K, Lentz K, Anderson M, Ajibola G, Phinius BB, Choga WT, Mbangiwa T, Powis KM, Sebunya T, Blackard JT, Lockman S, Moyo S, Shapiro R, Gaseitsiwe S. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana PloS one 15(8):e0237252 2020 [PMID: 32764801]
  7. Sivay MV, Palumbo PJ, Zhang Y, Cummings V, Guo X, Hamilton EL, McKinstry L, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort TGM, Eshleman SH. HIV drug resistance, phylogenetic analysis, and superinfection among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 [PMID: 32761071]
  8. Borrmann H, Davies R, Dickinson M, Pedroza-Pacheco I, Schilling M, Vaughan-Jackson A, Magri A, James W, Balfe P, Borrow P, McKeating JA, Zhuang X. Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication Scientific reports 10(1):13271 2020 [PMID: 32764708]
  9. Mbondji-Wonje C, Dong M, Zhao J, Wang X, Nanfack A, Ragupathy V, Sanchez AM, Denny TN, Hewlett I. Genetic variability of the U5 and downstream sequence of major HIV-1 subtypes and circulating recombinant forms Scientific reports 10(1):13214 2020 [PMID: 32764600]
  10. Srinivasan S, Chambers LC, Tapia KA, Hoffman NG, Munch MM, Morgan JL, Domogala D, Lowens MS, Proll S, Huang ML, Soge OO, Jerome KR, Golden MR, Hughes JP, Fredricks DN, Manhart LE. Urethral microbiota in men: Association of Haemophilus influenzae and Mycoplasma penetrans with nongonococcal urethritis Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 [PMID: 32750107]
  11. Carapito R, Mayr L, Molitor A, Verniquet M, Schmidt S, Tahar O, Partisani M, Rey D, Lambotte O, Bahram S, Moog C. A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome Genes and immunity 2020 [PMID: 32759994]
  12. Chang YM, Wieland A, Li ZR, Im SJ, McGuire DJ, Kissick HT, Antia R, Ahmed R. T cell receptor diversity and lineage relationship between virus-specific CD8 T cell subsets during chronic LCMV infection Journal of virology 2020 [PMID: 32759317]
  13. Leal L, Fehér C, Richart V, Torres B, García F. Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response Vaccines 8(3) 2020 [PMID: 32764508]
  14. Cheng C, Duan H, Xu K, Chuang GY, Corrigan AR, Geng H, O'Dell S, Ou L, Chambers M, Changela A, Chen X, Foulds KE, Sarfo EK, Jafari AJ, Hill KR, Kong R, Liu K, Todd JP, Tsybovsky Y, Verardi R, Wang S, Wang Y, Wu W, Zhou T, Arnold FJ, Doria-Rose NA, Koup RA, McDermott AB, Scorpio DG, Worobey M, Shapiro L, Mascola JR, Kwong PD. Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature Cell reports 32(5):107981 2020 [PMID: 32755575]
  15. Sivay MV, Palumbo PJ, Zhang Y, Cummings V, Guo X, Hamilton EL, McKinstry L, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort TGM, Eshleman SH. HIV drug resistance, phylogenetic analysis, and superinfection among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 [PMID: 32750117]
  16. Ueda G, Antanasijevic A, Fallas JA, Sheffler W, Copps J, Ellis D, Hutchinson GB, Moyer A, Yasmeen A, Tsybovsky Y, Park YJ, Bick MJ, Sankaran B, Gillespie RA, Brouwer PJ, Zwart PH, Veesler D, Kanekiyo M, Graham BS, Sanders RW, Moore JP, Klasse PJ, Ward AB, King NP, Baker D. Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens eLife 9 2020 [PMID: 32748788]
  17. Watanabe S, Fujino M, Saito Y, Ahmed N, Sato H, Sugimoto C, Okamura T, Hanaki K, Nakayama EE, Shioda T, Matsushima K, Ansari AA, Villinger F, Mori K. Protective Immune Responses Elicited by Deglycosylated Live-Attenuated Simian Immunodeficiency Virus Vaccine Are Associated with IL-15 Effector Functions Journal of immunology (Baltimore, Md. : 1950) 2020 [PMID: 32747501]
  18. Sprenger KG, Louveau JE, Murugan PM, Chakraborty AK. Optimizing immunization protocols to elicit broadly neutralizing antibodies Proceedings of the National Academy of Sciences of the United States of America 2020 [PMID: 32747563]
  19. Palli R, Seaton KE, Piepenbrink MS, Hural J, Goepfert PA, Laher F, Buchbinder SP, Churchyard G, Gray GE, Robinson HL, Huang Y, Janes H, Kobie JJ, Keefer MC, Tomaras GD, Thakar J. Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature Scientific reports 10(1):13031 2020 [PMID: 32747654]
  20. Loos C, Lauffenburger DA, Alter G. Dissecting the antibody-OME: past, present, and future Current opinion in immunology 65:89-96 2020 [PMID: 32755751]
  21. Sharifi H, Jahani Y, Mirzazadeh A, Ahmadi Gohari M, Nakhaeizadeh M, Shokoohi M, Eybpoosh S, Tohidinik HR, Mostafavi E, Khalili D, Hashemi Nazari SS, Karamouzian M, Haghdoost AA. Estimating COVID-19-Related Infections, Deaths, and Hospitalizations in Iran Under Different Physical Distancing and Isolation Scenarios International journal of health policy and management 2020 [PMID: 32772007]
  22. Gandhi M, Beyrer C, Goosby E. Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer Journal of general internal medicine 2020 [PMID: 32737790]
  23. Pathakumari B, Liang G, Liu W. Immune defence to invasive fungal infections: A comprehensive review Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 130:110550 2020 [PMID: 32739740]
  24. Gutjahr A, Papagno L, Vernejoul F, Lioux T, Jospin F, Chanut B, Perouzel E, Rochereau N, Appay V, Verrier B, Paul S. New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses EBioMedicine 58:102922 2020 [PMID: 32739871]
  25. Sharma VK, Misra B, McManus KT, Avula S, Nellaiappan K, Caskey M, Horowitz J, Nussenzweig MC, Seaman MS, Javeri I, Dey AK. Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration Antibodies (Basel, Switzerland) 9(3) 2020 [PMID: 32751063]
  26. Lewis MA, Harshbarger C, Bann C, Burrus O, Peinado S, Garner B, Khavjou O, Shrestha R, Karns S, Borkowf CB, Zulkiewicz B, Ortiz A, Galindo C, Piazza MD, Holm P, Marconi VC, Somboonwit C, Swaminathan S. Positive health check evaluation: A type 1 hybrid design randomized trial to decrease HIV viral loads in patients seen in HIV primary care Contemporary clinical trials :106097 2020 [PMID: 32738408]
  27. Bandali M, Schultz J, Than K, McGregor D, Archuleta S, Chadalawada S, Mundo W, Chastain D, Franco-Paredes C, Reno E, Henao-Martínez AF. Ensuring the Safety of Yellow Fever Vaccination in Travelers-The Experience at a Large U.S. Academic Medical Center in Colorado Tropical medicine and infectious disease 5(3) 2020 [PMID: 32751094]
  28. Zhou JO, Zaidi HA, Ton T, Fera D. The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage Frontiers in immunology 11:1529 2020 [PMID: 32765530]
  29. Huynh G, Nguyen TB, Cao NN, Phan MH, Dang TBH, Nguyen TNH. Hepatitis B Birth Dose among Children in District 2 Hospital, Ho Chi Minh City, Vietnam: Prevalence and Associated Factors The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2020:5680154 2020 [PMID: 32733622]
  30. Yuh T, Micheni M, Selke S, Oluoch L, Kiptinness C, Magaret A, Chohan B, Ngure K, Wald A, Mugo NR, Roxby AC. Sexually Transmitted Infections Among Kenyan Adolescent Girls and Young Women With Limited Sexual Experience Frontiers in public health 8:303 2020 [PMID: 32766197]
  31. Ilyas S, Chandrasekar PH. Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine Open forum infectious diseases 7(7):ofaa274 2020 [PMID: 32760747]
  32. Abraham J, Botto S, Mizuno N, Pryke K, Gall B, Boehm D, Sali TM, Jin H, Nilsen A, Gough M, Baird J, Chakhtoura M, Subra C, Trautmann L, Haddad EK, DeFilippis VR. Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner Frontiers in immunology 11:1430 2020 [PMID: 32733475]
  33. Fisher KL, Mabuka JM, Sivro A, Ngcapu S, Passmore JS, Osman F, Ndlovu B, Abdool Karim Q, Abdool Karim SS, Chung AW, Baxter C, Archary D. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women Frontiers in immunology 11:1274 2020 [PMID: 32733445]
  34. Villa S, Riccardi N, Canetti D, Alagna R, Castellotti P, Ferrarese M, Cirillo D, Barberis I, Bragazzi NL, Gazzaniga V, Ricucci V, Codecasa LR, Besozzi G, Martini M. From the past, a long way to future challenges for a greater control of tuberculosis Tuberculosis (Edinburgh, Scotland) 123:101948 2020 [PMID: 32741532]
  35. Mkandawire MJ, Muramira NM, Mraba N. A curious case of cough: Mounier-Kuhn syndrome in a Namibian female patient The Pan African medical journal 36:56 2020 [PMID: 32733627]
  36. Hakmi M, Bouricha EM, Kandoussi I, Harti JE, Ibrahimi A. Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis Bioinformation 16(4):301-306 2020 [PMID: 32773989]

Lassa virus

  1. Calvignac-Spencer S, Kouadio L, Couacy-Hymann E, Sogoba N, Rosenke K, Davison AJ, Leendertz F, Jarvis MA, Feldmann H, Ehlers B. Multiple DNA viruses identified in multimammate mouse (Mastomys natalensis) populations from across regions of sub-Saharan Africa Archives of virology 2020 [PMID: 32754877]
  2. Kim YJ, Cubitt B, Cai Y, Kuhn JH, Vitt D, Kohlhof H, de la Torre JC. Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro Viruses 12(8) 2020 [PMID: 32751087]

Marburg virus

  1. Kortepeter MG, Dierberg K, Shenoy ES, Cieslak TJ. Marburg Virus Disease: a Summary for Clinicians International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020 [PMID: 32758690]

Mycobacterium tuberculosis (tuberculosis)

  1. Niki M, Yoshiyama T, Nagai H, Miyamoto Y, Niki M, Oinuma KI, Tsubouchi T, Kaneko Y, Matsumoto S, Sasaki Y, Hoshino Y. Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development PloS one 15(8):e0237062 2020 [PMID: 32760105]
  2. Villar-Hernández R, Blauenfeldt T, García-García E, Muriel-Moreno B, De Souza-Galvão ML, Millet JP, Sabriá F, Sánchez-Montalvá A, Ruiz-Manzano J, Pilarte J, Jiménez MA, Centeno C, Martos C, Molina-Pinargote I, González-Díaz YD, Santiago J, Cantos A, Casas I, Guerola RM, Prat C, Andersen P, Latorre I, Ruhwald M, Domínguez J. Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination Scientific reports 10(1):13234 2020 [PMID: 32764560]
  3. Ayoub BM, Ramadan E, Ashoush N, Tadros MM, Hendy MS, Elmazar MM, Mousa SA. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration Die Pharmazie 75(8):375-380 2020 [PMID: 32758336]
  4. Roberts LM, Anderson R, Carmody A, Bosio CM. Validation and Application of a Bench Top Cell Sorter in a BSL-3 Containment Setting bioRxiv : the preprint server for biology 2020 [PMID: 32766573]
  5. Wassenaar TM, Buzard GS, Newman DJ. BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data Letters in applied microbiology 2020 [PMID: 32734625]
  6. Gupta PK. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19? Cellular immunology 356:104187 2020 [PMID: 32745670]
  7. Roy A, Infantes-Lorenzo JA, de la Cruz ML, Domínguez L, Álvarez J, Bezos J. Accuracy of tuberculosis diagnostic tests in small ruminants: A systematic review and meta-analysis Preventive veterinary medicine 182:105102 2020 [PMID: 32739695]
  8. Layre E. Trafficking of <i>Mycobacterium tuberculosis</i> Envelope Components and Release Within Extracellular Vesicles: Host-Pathogen Interactions Beyond the Wall Frontiers in immunology 11:1230 2020 [PMID: 32765485]
  9. Hsu LY, Lai LY, Hsieh PF, Lin TL, Lin WH, Tasi HY, Lee WT, Jou R, Wang JT. Two Novel <i>katG</i> Mutations Conferring Isoniazid Resistance in <i>Mycobacterium tuberculosis</i> Frontiers in microbiology 11:1644 2020 [PMID: 32760384]
  10. Wang W, Wang F, Peng Y, Liu K, Chen X, Chai C, Wang X, Chen B. Factors Associated with Health-Seeking Preference Among People Who Were Supposed to Cough for More Than 2 Weeks: A Cross-Sectional Study in Southeast China Patient preference and adherence 14:1173-1183 2020 [PMID: 32764890]
  11. Kamat S, Kumari M. BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? Frontiers in pharmacology 11:1050 2020 [PMID: 32754036]
  12. Pu F, Feng J, Xia P. Association between heparin-binding hemagglutinin and tuberculosis Advances in clinical and experimental medicine : official organ Wroclaw Medical University 29(7):893-897 2020 [PMID: 32735088]
  13. Moradi B, Sankian M, Amini Y, Gholoobi A, Meshkat Z. A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of <i>Mycobacterium tuberculosis</i> induced strong immune responses Iranian journal of basic medical sciences 23(7):909-914 2020 [PMID: 32774813]
  14. Troy A, Esparza-Gonzalez SC, Bartek A, Creissen E, Izzo L, Izzo AA. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon Tuberculosis (Edinburgh, Scotland) 123:101949 2020 [PMID: 32741537]
  15. Schwarz MGA, Corrêa PR, Malaga W, Guilhot C, Mendonça-Lima L. Mycobacterium bovis BCG moreau is naturally deficient in homologous recombination Tuberculosis (Edinburgh, Scotland) 123:101956 2020 [PMID: 32741533]
  16. Villa S, Riccardi N, Canetti D, Alagna R, Castellotti P, Ferrarese M, Cirillo D, Barberis I, Bragazzi NL, Gazzaniga V, Ricucci V, Codecasa LR, Besozzi G, Martini M. From the past, a long way to future challenges for a greater control of tuberculosis Tuberculosis (Edinburgh, Scotland) 123:101948 2020 [PMID: 32741532]
  17. Francisco NM, Allie N, Sebesho B, Ryffel B, Jacobs M. Complete ablation of tumor necrosis factor decreases the production of IgA, IgG, and IgM in experimental central nervous system tuberculosis Iranian journal of basic medical sciences 23(5):680-690 2020 [PMID: 32742607]

Nipah virus

  1. Cappelle J, Hoem T, Hul V, Furey N, Nguon K, Prigent S, Dupon L, Ken S, Neung C, Hok V, Pring L, Lim T, Bumrungsri S, Duboz R, Buchy P, Ly S, Duong V, Tarantola A, Binot A, Dussart P. Nipah virus circulation at human-bat interfaces, Cambodia Bulletin of the World Health Organization 98(8):539-547 2020 [PMID: 32773899]
  2. Mellors J, Tipton T, Longet S, Carroll M. Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics Frontiers in immunology 11:1450 2020 [PMID: 32733480]

Salmonella

  1. Rivero-Calle I, Gómez-Rial J, Bont L, Gessner BD, Kohn M, Dagan R, Payne DC, Bruni L, Pollard AJ, García-Sastre A, Faustman DL, Osterhaus A, Butler R, Giménez Sánchez F, Álvarez F, Kaforou M, Bello X, Martinón-Torres F. TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines Human vaccines & immunotherapeutics :1-14 2020 [PMID: 32755474]
  2. Kariuki S, Mbae C, Van Puyvelde S, Onsare R, Kavai S, Wairimu C, Ngetich R, Clemens J, Dougan G. High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic carriers in endemic informal settlements in Kenya PLoS neglected tropical diseases 14(8):e0008440 2020 [PMID: 32745137]

Shigella

  1. Lewnard JA, Rogawski McQuade ET, Platts-Mills JA, Kotloff KL, Laxminarayan R. Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: Evidence from the Global Enteric Multicenter Study PLoS neglected tropical diseases 14(8):e0008520 2020 [PMID: 32776938]

Variola major (Smallpox)

  1. Kumar A, Suryadevara NC, Wolf KJ, Wilson JT, Di Paolo RJ, Brien JD, Joyce S. Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model Scientific reports 10(1):13167 2020 [PMID: 32759969]
  2. Forsyth KS, Roy NH, Peauroi E, DeHaven BC, Wold ED, Hersperger AR, Burkhardt JK, Eisenlohr LC. Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading PLoS pathogens 16(8):e1008685 2020 [PMID: 32745153]
  3. Xiao Y, Zeng Y, Schante C, Joshi SB, Buchman GW, Volkin DB, Middaugh CR, Isaacs SN. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus Vaccine 2020 [PMID: 32741672]
  4. Yoshimura M, Shinmura Y, Takagi S, Kameyama K, Sonoda K, Koide F, Yoksan S, Kimachi K. Well-balanced immune response and protective efficacy induced by a single dose of live attenuated tetravalent dengue vaccine (KD-382) in monkeys Heliyon 6(7):e04506 2020 [PMID: 32760828]
  5. Ando J, Ngo MC, Ando M, Leen A, Rooney CM. Identification of protective T-cell antigens for smallpox vaccines Cytotherapy 2020 [PMID: 32747299]

Venezuelan equine encephalitis virus

  1. Nadia R, Oney OG, Gilles Q, Bruno C, Etienne D, Bruno C. Mutations on VEEV nsP1 relate RNA capping efficiency to ribavirin susceptibility Antiviral research :104883 2020 [PMID: 32750467]

Yersinia pestis (Plague)

  1. Roberts LM, Anderson R, Carmody A, Bosio CM. Validation and Application of a Bench Top Cell Sorter in a BSL-3 Containment Setting bioRxiv : the preprint server for biology 2020 [PMID: 32766573]

Click HERE to see the publications in the last month.